Shareholder alert: class action lawsuit filed on behalf of agenus inc. (agen) investors – holzer & holzer, llc encourages investors with significant losses to contact the firm

Atlanta, sept. 09, 2024 (globe newswire) -- a shareholder class action lawsuit has been filed against agenus inc. (“agenus” or “the company”) (nasdaq: agen). the lawsuit alleges that defendants made false and/or misleading statements and/or failed to disclose material information regarding the company's business, operations, and prospects, including allegations that: (i) the combination therapy of botensilimab and balstilimab was less effective than defendants had led investors to believe; and (ii) accordingly, botensilimab and balstilimab's clinical results, as well as their regulatory and commercial prospects, were overstated.
AGEN Ratings Summary
AGEN Quant Ranking